A fast, reliable solution for detecting and differentiating COVID-19, Influenza A, and Influenza B in symptomatic individuals. Designed for use with anterior nasal swabs, this test delivers accurate results within minutes, helping healthcare providers make informed decisions quickly.

✔ Detects SARS-CoV-2, Influenza A & B
Identifies viral antigens from three major respiratory infections in a single test, streamlining diagnosis.

✔ 15-Minute Rapid Results
Provides results within 15 minutes, enabling quicker patient management and treatment decisions.

✔ CLIA-Waived & Easy to Use
Designed for simple, efficient testing without the need for complex lab procedures.

✔ Long Shelf Life
Offers 16 months of stability (ongoing real-time study) for dependable stock management.

✔ High Accuracy & Performance
Validated against RT-PCR methods, ensuring reliable and consistent test results.

✔ Emergency Use Authorized (EUA)
Authorized for use under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, ensuring availability during public health emergencies.

✔ Quality Control Options Available
External quality controls ensure consistent and accurate test performance.

Not FDA cleared or approved but authorized under EUA for use by authorized laboratories.

Fast, Reliable, and Efficient Testing—When It Matters Most.